Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies

Neeland, Ian J.; Linge, Jennifer; Birkenfeld, Andreas L.

dc.contributor.author	Birkenfeld, Andreas L.
dc.date.accessioned	2024-12-17T10:36:04Z
dc.date.available	2024-12-17T10:36:04Z
dc.date.issued	2024
dc.identifier.issn	1462-8902
dc.identifier.uri	http://hdl.handle.net/10900/159692
dc.language.iso	en	de_DE
dc.publisher	Hoboken : Wiley	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/dom.15728	de_DE
dc.subject.ddc	610	de_DE
dc.title	Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies	de_DE
dc.type	Article	de_DE
utue.quellen.id	20241001000000_00998
utue.publikation.seiten	16-27	de_DE
utue.personen.roh	Neeland, Ian J.
utue.personen.roh	Linge, Jennifer
utue.personen.roh	Birkenfeld, Andreas L.
dcterms.isPartOf.ZSTitelID	Diabetes Obesity & Metabolism	de_DE
dcterms.isPartOf.ZS-Issue	S4	de_DE
dcterms.isPartOf.ZS-Volume	26	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE